The probiotic aisle has become one of the most successful marketing victories in modern supplement history. The shelves promise immunity, better moods, flatter stomachs, and clearer skin, and most of them deliver none of those things in any reliable way. The reason isn’t that probiotics don’t work. It’s that they work narrowly, and the version on the shelf is rarely the version that has been studied for what you actually want.
The mismatch between research and retail is where consumers lose the most money.
Strain specificity is everything
Probiotic effects are strain-specific, not species-specific, and certainly not genus-specific. Saying “Lactobacillus is good for you” is roughly as useful as saying “fungi are good for you” given that penicillin and a death cap mushroom are both fungi. The clinical evidence supports particular strains for particular conditions: Saccharomyces boulardii for antibiotic-associated diarrhea, certain Lactobacillus rhamnosus and Bifidobacterium lactis strains for traveler’s diarrhea, VSL#3 (now sold as Visbiome) for ulcerative colitis maintenance. A generic “ten-strain blend” sold at a pharmacy almost never matches a strain that has actually been trialed for the symptom you’re trying to treat. The blend looks comprehensive. The evidence base is mostly a different bottle.
The CFU number on the label is incomplete
Probiotic potency is reported in colony-forming units, and the label often states the count at time of manufacture rather than at expiration. Several independent lab tests, including ones by ConsumerLab and The Good Housekeeping Institute, have found that meaningful percentages of products fall below their stated CFU count by the time they reach the consumer, especially products that aren’t refrigerated. Even when potency holds, CFU count tells you nothing about whether the strain survives stomach acid, reaches the colon, or actually colonizes anything when it gets there. Many probiotics pass through transiently without altering the gut microbiome, which is fine if you’re treating an acute condition and useless if you’re trying to build a long-term population.
Where the evidence is genuinely strong
Probiotics have solid evidence for a handful of uses: preventing antibiotic-associated diarrhea (S. boulardii is the workhorse here), reducing severity and duration of acute infectious diarrhea in children, helping certain inflammatory bowel conditions when matched to the right strain, and modestly improving symptoms in some patients with irritable bowel syndrome. Beyond that list, the evidence thins quickly. Mood, weight loss, immunity in healthy adults, eczema in adults, autism, depression, and most of the marketing claims are supported by small studies, mixed results, or none at all. A 2018 Cochrane review and several JAMA-published meta-analyses have made the boundaries of legitimate use fairly clear, even if the marketing has not.
The takeaway
Match the strain to the indication, buy from manufacturers who report potency through expiration, refrigerate when required, and skip the broad-spectrum blends unless your clinician specifically recommended one. Probiotics are a real tool for narrow problems and a poor general health insurance policy. The shelf doesn’t know that, and your wallet will pay the difference if you don’t.
Leave a Reply